doxorubicin-hemoglobin conjugate (Hemosol)

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug Namedoxorubicin-hemoglobin conjugate (Hemosol)
Drug Alias NameHML-104HRC-202HRC-204
ClassificationBiologics
Mechanisms of ActionHemoglobins modulatorsTopoisomerase II inhibitorsVirus DNA polymerase inhibitors
TargetsVirus DNA polymeraseHemoglobinsTopoisomerase II
Therapy Area/IndicationsLiver NeoplasmsBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator Companies1608557 Ontario Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive Companies1608557 Ontario Inc
Active IndicationsN/A
Inactive IndicationsLiver NeoplasmsBacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A